Although a wide variety of nanoparticles (NPs) have been engineered for use as disease
markers or drug delivery agents, the number of nanomedicines in clinical use has hitherto …

A biomolecular coating, or biocorona, forms on the surface of engineered nanomaterials
(ENMs) immediately as they enter biological or environmental systems, defining their …

Conspectus Gold nanoparticles (AuNPs) exhibit unique size-and shape-dependent
properties not obtainable at the macroscale. Gold nanorods (AuNRs), with their morphology …

Lipid nanoparticles (LNPs) have successfully entered the clinic for the delivery of mRNA-and
siRNA-based therapeutics, most recently as vaccines for COVID-19. Nevertheless, there is a …

Nanoparticles in contact with proteins form a “corona” of proteins adsorbed on the
nanoparticle surface. Subsequent biological responses are then mediated by the adsorbed …

Nanoparticles (NPs) inevitably interact with proteins upon exposure to biological fluids,
leading to the formation of an adsorption layer known as the “protein corona”. This corona …

Gold nanoparticles (GNPs) are largely employed in diagnostics/biosensors and are among
the most investigated nanomaterials in biology/medicine. However, few GNPbased …

Nanomedicine plays a crucial role in the development of next-generation therapies. The use
of nanoparticles as drug delivery platforms has become a major area of research in …

Engineered gold nanoparticles (AuNPs) have great potential in many applications due to
their tunable optical properties, facile synthesis, and surface functionalization via thiol …

It is well known that protein corona affects the “biological identity” of nanoparticles (NPs),
which has been seen as both a challenge and an opportunity. Approaches have moved from …